ArticleTherapeutic advances in medical oncology2020

Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration.

Alja Zottel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.